drugset / Trial / NCT02254525

A Multicenter Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain

NCT02254525

Phase 3 Terminated 231 enrolled Biomendi S.A.U. Pivotal S.L. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to study the efficacy of intravenous administration of ibuprofen compared to placebo in patients with postoperative pain and evaluate its tolerability and safety profile.

Timeline

Start
2012-05
Primary completion
2014-06
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 800 mg Intravenous

Indications

No indication recorded.